相似文献
1
Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases.
Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii96-9. doi: 10.1136/ard.61.suppl_2.ii96.
2
Vitaxin applied molecular evolution.
Curr Opin Investig Drugs. 2000 Oct;1(2):199-203.
3
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002).
Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii2-7. doi: 10.1136/ard.61.suppl_2.ii2.
4
Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro.
J Cell Biochem. 2007 Oct 1;102(2):341-52. doi: 10.1002/jcb.21296.
5
The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.
Rheumatol Int. 2009 Aug;29(10):1255-7. doi: 10.1007/s00296-008-0816-0. Epub 2008 Dec 4.
6
[New strategies against autoaggressive immune system. Is rheumatism to be healable soon?].
MMW Fortschr Med. 2003 Oct 16;145(42):16.
7
Adalimumab for rheumatoid arthritis.
Expert Opin Biol Ther. 2006 Dec;6(12):1349-60. doi: 10.1517/14712598.6.12.1349.
8
Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.
Anticancer Agents Med Chem. 2006 Sep;6(5):407-28. doi: 10.2174/187152006778226530.
9
Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis.
Curr Drug Targets. 2003 Feb;4(2):123-31. doi: 10.2174/1389450033346830.
10
[Autoimmune aspects of treatment with TNF-alpha inhibitors].
Postepy Hig Med Dosw (Online). 2007 Aug 28;61:478-84.
引用本文的文献
1
Molecular basis of β2 integrin activation by talin unveils subunit-specific mechanisms of integrin signaling.
Cell Rep. 2025 May 27;44(5):115607. doi: 10.1016/j.celrep.2025.115607. Epub 2025 Apr 29.
2
The potential of autologous patient-derived circulating extracellular vesicles to improve drug delivery in rheumatoid arthritis.
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae101.
3
Monocytes and macrophages: Origin, homing, differentiation, and functionality during inflammation.
Heliyon. 2024 Apr 15;10(8):e29686. doi: 10.1016/j.heliyon.2024.e29686. eCollection 2024 Apr 30.
4
Radiotracers for Imaging of Fibrosis: Advances during the Last Two Decades and Future Directions.
Pharmaceuticals (Basel). 2023 Nov 1;16(11):1540. doi: 10.3390/ph16111540.
5
Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities.
Cell Commun Signal. 2023 Sep 28;21(1):266. doi: 10.1186/s12964-023-01264-4.
6
Long-Circulating Lipid Nanospheres Loaded with Flurbiprofen Axetil for Targeted Rheumatoid Arthritis Treatment.
Int J Nanomedicine. 2023 Sep 8;18:5159-5181. doi: 10.2147/IJN.S419502. eCollection 2023.
7
[Ga]Ga-NODAGA-E[(cRGDyK)] angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure.
J Nucl Cardiol. 2023 Oct;30(5):2073-2084. doi: 10.1007/s12350-023-03265-9. Epub 2023 May 1.
8
Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis.
Int J Mol Sci. 2023 Apr 17;24(8):7400. doi: 10.3390/ijms24087400.
9
Targeted and responsive biomaterials in osteoarthritis.
Theranostics. 2023 Jan 16;13(3):931-954. doi: 10.7150/thno.78639. eCollection 2023.
10
Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis.
Int J Mol Sci. 2022 Jun 25;23(13):7071. doi: 10.3390/ijms23137071.
本文引用的文献
1
A three-state mechanism of integrin activation and signal transduction for integrin alpha(v)beta(3).
Chembiochem. 2002 May 3;3(5):470-3. doi: 10.1002/1439-7633(20020503)3:5<470::AID-CBIC470>3.0.CO;2-X.
2
Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4556-61. doi: 10.1073/pnas.052523599.
3
Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation.
Nat Struct Biol. 2002 Apr;9(4):282-7. doi: 10.1038/nsb779.
4
Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.
Science. 2002 Apr 5;296(5565):151-5. doi: 10.1126/science.1069040. Epub 2002 Mar 7.
5
Integrin-mediated death: an explanation of the integrin-knockout phenotype?
Nat Med. 2002 Mar;8(3):193-4. doi: 10.1038/nm0302-193.
6
Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
Nat Med. 2002 Jan;8(1):27-34. doi: 10.1038/nm0102-27.
7
Integrin indecision.
Nat Med. 2002 Jan;8(1):14-6. doi: 10.1038/nm0102-14.
8
Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells.
Mol Cell Biochem. 2001 Aug;224(1-2):81-9. doi: 10.1023/a:1011947301849.
9
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins.
J Cell Biol. 2001 Oct 29;155(3):459-70. doi: 10.1083/jcb.200106070.
10
Podosomes in osteoclast-like cells: structural analysis and cooperative roles of paxillin, proline-rich tyrosine kinase 2 (Pyk2) and integrin alphaVbeta3.
J Cell Sci. 2001 Aug;114(Pt 15):2775-86. doi: 10.1242/jcs.114.15.2775.
Zotero 插件